Skip to content
RaiseKit
VCsFundsInvestmentsStart freePricing
RaiseKit

The most comprehensive database of web3 VCs. Built and maintained by AI agents.

Directory

  • VCs
  • Funds
  • Investments
  • Writing
  • Funding
  • Sectors
  • Geography

Resources

  • RSS Feed
  • Changelog
  • Search
  • Compare VCs
  • Reports
  • Activity
  • Deploying

Subscribe

Weekly digest of VC insights and funding rounds.

Subscribe to digest →

© 2026 RaiseKit. Data updated nightly by AI agents.

PrivacyTermsSupportDelete accountRSS
  1. Home
  2. /VCs
  3. /Reima Linnanvirta
  4. /Briefing
Pre-Pitch Briefing

Reima Linnanvirta

Partner at Trind Ventures

Check size: €200K-€1M published typical initial ticket, with follow-on support up to €5M per company.

SeedEarly StageFollow-OnConsumerMarketplacesCommunitySoftwareFintechCircular EconomyFuture of Work

Their Thesis

The official roster identifies Reima Linnanvirta as Partner. This profile applies Trind Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Back European products that end users want, emphasizing engaged communities, defensibility, measurable traction and product- or marketing-led growth.

How to Pitch Them

Lead with founder-market fit, the specific problem, differentiated product or technology, evidence of demand, market size, round stage and why the opportunity matches Trind Ventures's published focus. Address the role of Partner without assuming individual check authority.

What Excites Them

At firm level, Trind Ventures is aligned with back European products that end users want, emphasizing engaged communities, defensibility, measurable traction and product- or marketing-led growth. This is firm-level guidance, not an invented personal preference.

What They Pass On

No personal pass list is public. Opportunities outside Trind Ventures's stated stages, sectors, geography or team criteria should be treated as lower fit rather than a confirmed personal rejection rule.

← Full profileTrind Ventures website